Skip to content

Robotically Assisted Treadmill Training in Spinal Cord Injury (SCI)

Cardiovascular Parameters for Lokomat Training in Chronic Incomplete SCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00385918
Enrollment
18
Registered
2006-10-11
Start date
2006-10-31
Completion date
2011-06-30
Last updated
2014-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paraplegia, Quadriplegia, Spinal Cord Injury, Tetraplegia

Keywords

Cardiovascular Fitness, Exercise, Gait, Spinal Cord Injury, Treadmill Training

Brief summary

This proposal investigates the hypothesis that progressive aerobic exercise with Lokomat is feasible in people with motor incomplete spinal cord injury, and three months of training will improve cardiovascular fitness and gait functionality when compared to physical therapy controls

Detailed description

Little information is available about the cardiovascular effects of robotically assisted partial weight support treadmill training devices such as Lokomat in chronic incomplete spinal cord injured subjects. Task-oriented aerobic exercise has the potential to improve both neuromuscular function and cardiovascular metabolic fitness in neurological populations. Since spinal cord injured individuals are at an increased risk of developing premature cardiovascular disease, the investigation of robotic-assisted interventions in spinal cord injury (SCI) such as the Lokomat may have important health benefits in both cardiovascular fitness as well as functional mobility. This proposal investigates the hypothesis that progressive aerobic exercise with Lokomat is feasible in motor incomplete SCI, and three months of training will improve cardiovascular fitness and gait functionality when compared to physical therapy controls. We propose a two-phase study to examine the feasibility, reliability and utility of aerobic exercise metabolic testing and training during robotically assisted partial weight support treadmill walking in individuals with chronic motor incomplete spinal cord injury (CMISCI). During the first phase of the study we will manipulate Lokomat training parameters of treadmill speed and percent of partial weight support to assess the effect of these changes on heart rate, perceived exertion, and oxygen consumption in untrained chronic motor incomplete spinal cord injured subjects. Subjects will be asked to maintain cardiovascular or muscular effort during testing and will be monitored in this regard by the force biofeedback system built into the Lokomat. After determining threshold levels for initial cardiovascular response, submaximal and then peak exercise testing will be attempted. These studies will be repeated on a separate day to determine the reliability of the testing results. Thirty-six subjects with varying levels of injury between C4 and L2 and ASIA (American Spinal Injury) Impairment Scales of C and D will be recruited. We anticipate that subjects with greater ASIA motor scores will require either a faster initial treadmill speed or less partial weight support to produce an initial cardiovascular response. It is also anticipated that peak exercise testing using open circuit spirometry with subjects on the Lokomat will be a feasible, reliable and valid measurement. This phase of the study will be aimed at establishing guidelines for determining initial training parameters for use in an aerobic exercise protocol using the Lokomat. The second phase of this pilot study will be a controlled trial of three-month progressive aerobic Lokomat exercise in chronic incomplete spinal cord injured subjects. The aim of this trial will be to determine whether progressive Lokomat training will improve cardiovascular fitness and ambulatory function when compared to matched impairment severity CMISCI subjects receiving the same duration of usual physical therapy care. Thirty-six subjects will be recruited into this phase of the study. Open spirometric evaluation of cardiovascular parameters as outlined in phase one of the proposal will be measured at baseline, 1 months, and 3 months. Initial, six-week and post-study ambulatory function evaluations including the WISCI (Walking Index for Spinal Cord Injury), a timed 10 meter walk, a measured walk over 6 minutes, and a gait analysis will also be determined. It is hypothesized that aerobic Lokomat exercise will improve cardiovascular fitness as determined by an increase in VO2 (oxygen consumption) peak and improve function as determined by timed walks and gait parameters in these subjects. The results of this pilot and development study will provide the necessary information to design larger randomized clinical trials.

Interventions

The Lokomat is a robotically assisted partial weight suspension treadmill training device that has the potential to restore leg function in persons with incomplete leg paralysis.

OTHERHome stretching then Lokomat training

Patients will be instructed by a physical therapist on how to perform a home stretching protocol 3 times per week for 3 months. The stretching will be monitored via telephone by the study coordinator. This will be an active control arm. After 3 months the patients will be crossed over to Lokomat training for an additional 3 months. This training will be the same as given to the individuals originally randomized to the Lokomat treatment intervention.

Sponsors

University of Maryland
CollaboratorOTHER
Kernan Orthopaedics and Rehabilitation Hospital
CollaboratorUNKNOWN
US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Acute onset Spinal Cord Injury or Disease at least 12 months prior to enrollment * Age 18 to 80 * Level of injury from C4 to L2 * ASIA impairment scale either C or D * Able to tolerate standing frame for at least 30 minutes

Exclusion criteria

* History of unstable angina, recent MI (myocardial infarction), CHF (congestive heart failure) or clinically significant valvular dysfunction * History of recent hospitalization (\<3 months) for a major medical problem

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.0, 1.5 and 3, 4.5, and 6 monthsPeak oxygen consumption during arm cycle ergometry as a measure of cardiovascular fitness. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
Cardiovascular Fitness as Determined by Lokomat Peak VO2 Assessments0, 1.5 and 3, 4.5, and 6 monthsPeak V02 measurements taken during Lokomat exercise in order to measure cardiovascular fitness. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Secondary

MeasureTime frameDescription
Lean Muscle MassMeasured at Baseline (Time point 0) and 3 monthsDXA measurement of total lean muscle mass. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
Bone Mineral ContentMeasured at Baseline (Time point 0), 3, and 6 monthsDXA assessment of bone mineral content. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
Body MassMeasured at Baseline (Time point 0), 3, and 6 monthsDXA assessment of total body mass. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
10-meter WalkMeasured at Baseline (Time point 0) and 3 monthsA functional capacity test to measure speed. This measure was only done on those participants that were able to walk, which represented 9 in the Lokomat training group out of the 12 total randomized to Lokomat training, and 5 out of the 6 who were randomized to home stretching. Note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
Step Activity MonitorMeasured at Baseline (Time point 0) and 3 monthsThe step activity monitor measures the total steps taken by an individual over a 48 hour time frame in the home environment. This measure was only done on those participants that were able to walk in the community and did not use a wheelchair for community mobility, which represented 7 in the Lokomat training group out of the 12 total randomized to Lokomat training and 5 out of 6 of the people randomized to home stretching. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
Six Minute WalkMeasured Baseline (Time point 0) and 3 monthsA functional capacity test to evaluate walking distance during a 6-minute time frame. This measure was only done on those participants that were able to walk for 6 minutes, which represented 9 in the Lokomat training group out of the 12 total randomized to Lokomat training, and 5 out of the 6 randomized to the home stretching group. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.
Percent Body FatMeasured at Baseline (Time point 0), 3, and 6 monthsAn assessment of percent body fat as determined by DXA analysis. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Countries

United States

Participant flow

Recruitment details

Dates of recruitment: April 2007 through 2010. Location of recruitment: Kernan Hospital Spinal Cord Injury Clinic and Baltimore VAMC Spinal Cord Support Clinic.

Pre-assignment details

Participants all underwent baseline and feasibility testing prior to randomization in either of the two arms.

Participants by arm

ArmCount
Lokomat Exercise
Subjects will receive active exercise treatment in the Lokomat device 3 times per week for 3 months. Each session will last approximately 45 minutes. Lokomat Training : The Lokomat is a robotically assisted partial weight suspension treadmill training device that has the potential to restore leg function in persons with incomplete leg paralysis.
12
Home Stretching Then Lokomat Exercise
Patients will participate in a home stretching program for 3 months. They will then be crossed over to Lokomat treatment for an additional 3 months. Home stretching protocol : Patients will be instructed by a physical therapist on how to perform a home stretching protocol 3 times per week for 3 months. The stretching will be monitored via telephone by the study coordinator. This will be an active control arm.
6
Total18

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Feasibility & Baseline Measurement Phaseoutside of inclusion criteria008
Feasibility & Baseline Measurement PhasePhysician Decision001
Feasibility & Baseline Measurement PhaseWithdrawal by Subject005
Intervention Phase After RandomizationLost to Follow-up100
Intervention Phase After RandomizationPhysician Decision100
Intervention Phase After RandomizationWithdrawal by Subject100

Baseline characteristics

CharacteristicLokomat ExerciseHome Stretching Then Lokomat ExerciseTotal
Age, Continuous51.5 years
STANDARD_DEVIATION 12.7
52.0 years
STANDARD_DEVIATION 15.4
51.7 years
STANDARD_DEVIATION 13.2
ASIA Impairment Scale
ASIA impairment C
2 participants0 participants2 participants
ASIA Impairment Scale
ASIA impairment D
10 participants6 participants16 participants
Body Mass80.8 kg
STANDARD_DEVIATION 14.6
94.3 kg
STANDARD_DEVIATION 25
85.3 kg
STANDARD_DEVIATION 19.1
Impairment Function
Paraplegia
4 participants0 participants4 participants
Impairment Function
Tetraplegia
8 participants6 participants14 participants
Lower Extremity Motor Score34.2 units on a scale
STANDARD_DEVIATION 11.5
36.2 units on a scale
STANDARD_DEVIATION 8.4
34.8 units on a scale
STANDARD_DEVIATION 10.3
Sex: Female, Male
Female
1 Participants0 Participants1 Participants
Sex: Female, Male
Male
11 Participants6 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
5 / 153 / 6
serious
Total, serious adverse events
1 / 150 / 6

Outcome results

Primary

Cardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.

Peak oxygen consumption during arm cycle ergometry as a measure of cardiovascular fitness. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: 0, 1.5 and 3, 4.5, and 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Pre (time frame 0) VO2 peak arm ergometry20.0 ml/kg/minStandard Deviation 6.5
Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Midpoint (1.5 months) VO2 peak arm ergometry19.8 ml/kg/minStandard Deviation 5.4
Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Post (3 months) VO2 peak arm ergometry21.7 ml/kg/minStandard Deviation 7.5
Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Home stretch group (3 months) pre Lokomat trainingNA ml/kg/min
Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Home stretch group midpoint (4.5 m) LokomatNA ml/kg/min
Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Home stretch group post Lokomat (6 mod)NA ml/kg/min
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Home stretch group midpoint (4.5 m) Lokomat12.3 ml/kg/minStandard Deviation 5
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Pre (time frame 0) VO2 peak arm ergometry13.5 ml/kg/minStandard Deviation 3.3
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Home stretch group (3 months) pre Lokomat training13.2 ml/kg/minStandard Deviation 2.9
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Midpoint (1.5 months) VO2 peak arm ergometry11.1 ml/kg/minStandard Deviation 2.1
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Home stretch group post Lokomat (6 mod)13.0 ml/kg/minStandard Deviation 4.1
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Arm Cycle Ergometry VO2 Peak Assessments.Post (3 months) VO2 peak arm ergometry13.7 ml/kg/minStandard Deviation 2.5
Primary

Cardiovascular Fitness as Determined by Lokomat Peak VO2 Assessments

Peak V02 measurements taken during Lokomat exercise in order to measure cardiovascular fitness. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: 0, 1.5 and 3, 4.5, and 6 months

Population: A single outlier point in the baseline data in one control subject was noted. Laboratory journal notes for this subject indicated that this individual had far more episodes of robotic treadmill stops during his baseline testing due to a high degree of spasticity. Given this, we felt justified in excluding this outlier from further data analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsPre (time frame 0) VO2 peak20.2 ml/kg/minStandard Deviation 7.4
Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsMidpoint (1.5 months) VO2 peak22.5 ml/kg/minStandard Deviation 7.9
Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsPost_VO2 peak (3 months)22.7 ml/kg/minStandard Deviation 7.5
Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsHome stretch group at 3 months pre Lokomat (n=6)NA ml/kg/min
Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsHome stretch group VO2 peak midpoint (4.5 months)NA ml/kg/min
Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsHome stretch group VO2 peak post (6 months)NA ml/kg/min
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsHome stretch group VO2 peak midpoint (4.5 months)19.3 ml/kg/minStandard Deviation 8.4
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsPre (time frame 0) VO2 peak12.9 ml/kg/minStandard Deviation 4.4
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsHome stretch group at 3 months pre Lokomat (n=6)18.7 ml/kg/minStandard Deviation 8.6
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsMidpoint (1.5 months) VO2 peak11.6 ml/kg/minStandard Deviation 5.1
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsHome stretch group VO2 peak post (6 months)18.7 ml/kg/minStandard Deviation 7
Home Stretching Then Lokomat TrainingCardiovascular Fitness as Determined by Lokomat Peak VO2 AssessmentsPost_VO2 peak (3 months)13.4 ml/kg/minStandard Deviation 3.9
Secondary

10-meter Walk

A functional capacity test to measure speed. This measure was only done on those participants that were able to walk, which represented 9 in the Lokomat training group out of the 12 total randomized to Lokomat training, and 5 out of the 6 who were randomized to home stretching. Note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured at Baseline (Time point 0) and 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat Training10-meter Walk10-meter walk_Baseline (0 months)23.0 secondsStandard Deviation 17.5
Lokomat Training10-meter Walk10-meter walk_post (3 months)21.3 secondsStandard Deviation 17.8
Home Stretching Then Lokomat Training10-meter Walk10-meter walk_Baseline (0 months)16.5 secondsStandard Deviation 7.6
Home Stretching Then Lokomat Training10-meter Walk10-meter walk_post (3 months)14.6 secondsStandard Deviation 7.1
Secondary

Body Mass

DXA assessment of total body mass. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured at Baseline (Time point 0), 3, and 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingBody MassBody Mass_Baseline80.8 kgStandard Deviation 14.6
Lokomat TrainingBody MassBody Mass_Post (3 months)79.8 kgStandard Deviation 15
Lokomat TrainingBody MassHome stretch group pre (3 months) Body massNA kg
Lokomat TrainingBody MassHome stretch group post Body mass (6 months)NA kg
Home Stretching Then Lokomat TrainingBody MassHome stretch group post Body mass (6 months)94.8 kgStandard Deviation 22.1
Home Stretching Then Lokomat TrainingBody MassBody Mass_Baseline94.3 kgStandard Deviation 25
Home Stretching Then Lokomat TrainingBody MassHome stretch group pre (3 months) Body mass93.4 kgStandard Deviation 22.8
Home Stretching Then Lokomat TrainingBody MassBody Mass_Post (3 months)92.3 kgStandard Deviation 23.3
Secondary

Bone Mineral Content

DXA assessment of bone mineral content. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured at Baseline (Time point 0), 3, and 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingBone Mineral ContentBone Mineral Content_Baseline (0 months)3.04 kgStandard Deviation 0.46
Lokomat TrainingBone Mineral ContentBone Mineral Content_Post (3 months)3.02 kgStandard Deviation 0.44
Lokomat TrainingBone Mineral ContentHome stretch Pre Bone Mineral Content (3 months)NA kg
Lokomat TrainingBone Mineral ContentHome stretch Post Bone Mineral Content (6 months)NA kg
Home Stretching Then Lokomat TrainingBone Mineral ContentHome stretch Post Bone Mineral Content (6 months)3.15 kgStandard Deviation 0.5
Home Stretching Then Lokomat TrainingBone Mineral ContentBone Mineral Content_Baseline (0 months)3.18 kgStandard Deviation 0.46
Home Stretching Then Lokomat TrainingBone Mineral ContentHome stretch Pre Bone Mineral Content (3 months)3.17 kgStandard Deviation 0.56
Home Stretching Then Lokomat TrainingBone Mineral ContentBone Mineral Content_Post (3 months)3.16 kgStandard Deviation 0.55
Secondary

Lean Muscle Mass

DXA measurement of total lean muscle mass. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured at Baseline (Time point 0) and 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingLean Muscle MassHome stretch Group Pre Lean Muscle Mass (3 months)NA kg
Lokomat TrainingLean Muscle MassLean Muscle Mass_Baseline (0 months)51.2 kgStandard Deviation 8.5
Lokomat TrainingLean Muscle MassHome muscle Group Post Lean Muscle Mass (6 months)NA kg
Lokomat TrainingLean Muscle MassLean Muscle Mass_Post (3 months)51.4 kgStandard Deviation 8
Home Stretching Then Lokomat TrainingLean Muscle MassHome muscle Group Post Lean Muscle Mass (6 months)59.9 kgStandard Deviation 10.2
Home Stretching Then Lokomat TrainingLean Muscle MassLean Muscle Mass_Baseline (0 months)58.9 kgStandard Deviation 11.3
Home Stretching Then Lokomat TrainingLean Muscle MassHome stretch Group Pre Lean Muscle Mass (3 months)59.0 kgStandard Deviation 9.5
Home Stretching Then Lokomat TrainingLean Muscle MassLean Muscle Mass_Post (3 months)58.3 kgStandard Deviation 9.6
Secondary

Percent Body Fat

An assessment of percent body fat as determined by DXA analysis. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured at Baseline (Time point 0), 3, and 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingPercent Body FatPercent Body Fat_Baseline (time 0)33.6 percent of total massStandard Deviation 7.9
Lokomat TrainingPercent Body FatPercent Body Fat_Post (3 months)32.4 percent of total massStandard Deviation 7.7
Lokomat TrainingPercent Body FatHome stretch group pre %Body fat (3 months)NA percent of total mass
Lokomat TrainingPercent Body FatHome stretch group post %Body fat (6 months)NA percent of total mass
Home Stretching Then Lokomat TrainingPercent Body FatHome stretch group post %Body fat (6 months)33.7 percent of total massStandard Deviation 6.4
Home Stretching Then Lokomat TrainingPercent Body FatPercent Body Fat_Baseline (time 0)34.2 percent of total massStandard Deviation 6.9
Home Stretching Then Lokomat TrainingPercent Body FatHome stretch group pre %Body fat (3 months)33.3 percent of total massStandard Deviation 7.2
Home Stretching Then Lokomat TrainingPercent Body FatPercent Body Fat_Post (3 months)33.3 percent of total massStandard Deviation 7.4
Secondary

Six Minute Walk

A functional capacity test to evaluate walking distance during a 6-minute time frame. This measure was only done on those participants that were able to walk for 6 minutes, which represented 9 in the Lokomat training group out of the 12 total randomized to Lokomat training, and 5 out of the 6 randomized to the home stretching group. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured Baseline (Time point 0) and 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingSix Minute WalkSix-minute Walk_Baseline (0 months)179.5 metersStandard Deviation 76.4
Lokomat TrainingSix Minute WalkSix-minute Walk_Post (3 months)201.6 metersStandard Deviation 94.6
Home Stretching Then Lokomat TrainingSix Minute WalkSix-minute Walk_Baseline (0 months)203.0 metersStandard Deviation 108.3
Home Stretching Then Lokomat TrainingSix Minute WalkSix-minute Walk_Post (3 months)250.8 metersStandard Deviation 136.3
Secondary

Step Activity Monitor

The step activity monitor measures the total steps taken by an individual over a 48 hour time frame in the home environment. This measure was only done on those participants that were able to walk in the community and did not use a wheelchair for community mobility, which represented 7 in the Lokomat training group out of the 12 total randomized to Lokomat training and 5 out of 6 of the people randomized to home stretching. Please note that at times the home stretching group would have a second set of measurements at 3 months - one post the 3 month time interval and one later in the 3rd month if there was some delay in initiating the crossover to Lokomat training. This sometimes occurred if the time it would take to complete all of the required studies (e.g. DXA, other secondary measures) was prolonged because of logistical issues.

Time frame: Measured at Baseline (Time point 0) and 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat TrainingStep Activity MonitorAverage 24-hour step total_Post (3 months)1579.9 stepsStandard Deviation 1078.4
Lokomat TrainingStep Activity MonitorAverage 24-hour step total_Baseline (0 months)1674.8 stepsStandard Deviation 1129.1
Home Stretching Then Lokomat TrainingStep Activity MonitorAverage 24-hour step total_Post (3 months)1652.4 stepsStandard Deviation 1707.1
Home Stretching Then Lokomat TrainingStep Activity MonitorAverage 24-hour step total_Baseline (0 months)1531.3 stepsStandard Deviation 1576.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026